217
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Effects of loratadine, a histamine H1 receptor antagonist, on the skeletal system of young male rats

ORCID Icon, , , , ORCID Icon & ORCID Icon
Pages 3357-3367 | Published online: 23 Sep 2019

References

  • Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115(12):3318–3325. doi:10.1172/JCI2707116322775
  • Williams KM. Update on bone health in pediatric chronic disease. Endocrinol Metab Clin North Am. 2016;45(2):433–441. doi:10.1016/j.ecl.2016.01.00927241973
  • Pols DHJ, Wartna JB, van Alphen EI, et al. Interrelationships between atopic disorders in children: a meta-analysis based on ISAAC questionnaires. PLoS One. 2015;10(7):e0131869. doi:10.1371/journal.pone.013186926135565
  • Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733–743. doi:10.1016/S0140-6736(06)69283-016935684
  • Fitzsimons R, van der Poel LA, Thornhill W, du Toit G, Shah N, Brough HA. Antihistamine use in children. Arch Dis Child Educ Pract Ed. 2015;100(3):122–131. doi:10.1136/archdischild-2013-30444625147323
  • Lieberman P. Histamine, antihistamines, and the central nervous system. Allergy Asthma Proc. 2009;30(5):482–486. doi:10.2500/aap.2009.30.326419843401
  • Lieberman P. The basics of histamine biology. Ann Allergy Asthma Immunol. 2011;106(2 Suppl):S2–S5. doi:10.1016/j.anai.2010.08.00521277530
  • Biosse-Duplan M, Baroukh B, Dy M, de Vernejoul MC, Saffar JL. Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol. 2009;174(4):1426–1434. doi:10.2353/ajpath.2009.08087119264900
  • Deyama Y, Kikuiri T, Ohnishi GI, et al. Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts. Biochem Biophys Res Commun. 2002;298(2):240–246. doi:10.1016/s0006-291x(02)02440-312387822
  • Ikawa Y, Yonekawa T, Ohkuni Y, Kuribayashi M, Fukino K, Ueno K. A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts. J Toxicol Sci. 2007;32(5):555–564. doi:10.2131/jts.32.55518198485
  • Fouilloux I, Duplan MB, Baroukh B, Cherruau M, Saffar JL, Lesclous P. Mast cell activation and degranulation occur early during induction of periosteal bone resorption. Bone. 2006;38(1):59–66. doi:10.1016/j.bone.2005.07.02616249129
  • Lesclous P, Schramm F, Gallina S, Baroukh B, Guez D, Saffar JL. Histamine mediates osteoclastic resorption only during the acute phase of bone loss in ovariectomized rats. Exp Physiol. 2006;91(3):561–570. doi:10.1113/expphysiol.2006.03321716513821
  • Dobigny C, Saffar JL. H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol. 1997;173(1):10–18. doi:10.1002/(SICI)1097-4652(199710)173:1<10::AID-JCP2>3.0.CO;2-M9326444
  • Aasarød KM, Stunes AK, Mosti MP, et al. Effects of the histamine 1 receptor antagonist cetirizine on the osteoporotic phenotype in H+/K+ATPase beta subunit KO mice. J Cell Biochem. 2016;117(9):2089–2096. doi:10.1002/jcb.2551426869358
  • Degboé Y, Eischen M, Nigon D, et al. Prevalence and risk factors for fragility fracture in systemic mastocytosis. Bone. 2017;105:219–225. doi:10.1016/j.bone.2017.09.00528919366
  • Rossini M, Zanotti R, Orsolini G, et al. Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis. Osteoporos Int. 2016;27(8):2411–2421. doi:10.1007/s00198-016-3539-126892042
  • Ferencz V, Meszaros S, Csupor E, et al. Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy. Osteoporos Int. 2006;17(3):484–491. doi:10.1007/s00198-005-0011-z16432646
  • Corley DA, Kubo A, Zhao W, Quesenberry C. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010;139(1):93–101. doi:10.1053/j.gastro.2010.03.05520353792
  • de Vries F, Cooper AL, Cockle SM, van Staa TP, Cooper C. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates. Osteoporos Int. 2009;20(12):1989–1998. doi:10.1007/s00198-009-0891-419333676
  • Eom CS, Park SM, Myung SK, Yun JM, Ahn JS. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med. 2011;9(3):257–267. doi:10.1370/afm.124321555754
  • Kinjo M, Setoguchi S, Solomon DH. Antihistamine therapy and bone mineral density: analysis in a population-based US sample. Am J Med. 2008;121(12):1085–1091. doi:10.1016/j.amjmed.2008.06.03619028205
  • Kwok CS, Yeong JKY, Loke YK. Meta-analysis: risk of fractures with acid-suppressing medication. Bone. 2011;48(4):768–776. doi:10.1016/j.bone.2010.12.01521185417
  • Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int. 2006;79(2):76–83. doi:10.1007/s00223-006-0021-716927047
  • Lesclous P, Guez D, Saffar JL. Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H2 receptor antagonist cimetidine. Bone. 2002;30(1):131–136.11792575
  • Lesclous P, Guez D, Baroukh B, Vignery A, Saffar JL. Histamine participates in the early phase of trabecular bone loss in ovariectomized rats. Bone. 2004;34(1):91–99. doi:10.1016/j.bone.2003.08.00714751566
  • Folwarczna J, Janas A, Pytlik M, Śliwiński L, Wiercigroch M, Brzęczek A. Modifications of histamine receptor signaling affect bone mechanical properties in rats. Pharmacol Rep. 2014;66(1):93–99. doi:10.1016/j.pharep.2013.08.01024905313
  • Tyan ML. Effect of promethazine on lumbar vertebral bone mass in postmenopausal women. J Intern Med. 1993;234(2):143–148.8340736
  • Abrahamsen B, Vestergaard P. Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using national prescription data. Bone. 2013;57(1):269–271. doi:10.1016/j.bone.2013.08.01323973557
  • Guo J, Li W, Wu Y, et al. Meclizine prevents ovariectomy-induced bone loss and inhibits osteoclastogenesis partially by upregulating PXR. Front Pharmacol. 2017;8:693. doi:10.3389/fphar.2017.0069329046637
  • Tyan ML, Blahd WH. Effects of H1 blocking agents on age-related osteopenia in the mouse. Mech Ageing Dev. 1987;38(3):287–293.2887716
  • Rico H, Gómez M, Revilla M, et al. Effects of promethazine on bone mass and on bone remodeling in ovariectomized rats: a morphometric, densitometric, and histomorphometric experimental study. Calcif Tissue Int. 1999;65(4):272–275. doi:10.1007/s00223990069710485976
  • Matsushita M, Hasegawa S, Kitoh H, et al. Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene. Endocrinology. 2015;156(2):548–554. doi:10.1210/en.2014-191425456072
  • Meh A, Sprogar Š, Vaupotic T, et al. Effect of cetirizine, a histamine (H1) receptor antagonist, on bone modeling during orthodontic tooth movement in rats. Am J Orthod Dentofac Orthop. 2011;139(4):e323–e329. doi:10.1016/j.ajodo.2009.11.013
  • Turner CH, Burr DB. Basic biochemical measurements of bone: a turtorial. Bone. 1993;14(4):595–608. doi:10.1016/8756-3282(93)90081-K8274302
  • Folwarczna J, Pytlik M, Janiec W. Effects of doxycycline on development of changes in histomorphometric parameters of bones induced by bilateral ovariectomy in rats. Pol J Pharmacol. 2003;55(3):433–441.14506323
  • Folwarczna J, Pytlik M, Zych M, et al. Favorable effect of moderate dose caffeine on the skeletal system in ovariectomized rats. Mol Nutr Food Res. 2013;57(10):1772–1784. doi:10.1002/mnfr.20130012323754597
  • Dempster DW, Compston JE, Drezner MK, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 2013;28(1):2–17. doi:10.1002/jbmr.180523197339
  • Villemure I, Stokes IAF. Growth plate mechanics and mechanobiology. A survey of present understanding. J Biomech. 2009;42(12):1793–1803. doi:10.1016/j.jbiomech.2009.05.02119540500
  • Stürmer EK, Seidlová-Wuttke D, Sehmisch S, et al. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J Bone Miner Res. 2006;21(1):89–96. doi:10.1359/JBMR.05091316355277
  • Rennie L, Court-Brown CM, Mok JYQ, Beattie TF. The epidemiology of fractures in children. Injury. 2007;38(8):913–922. doi:10.1016/j.injury.2007.01.03617628559
  • Naranje SM, Erali RA, Warner WC, Sawyer JR, Kelly DM. Epidemiology of pediatric fractures presenting to emergency departments in the United States. J Pediatr Orthop. 2016;36(4):e45–e48. doi:10.1097/BPO.000000000000059526177059
  • Campion SN, Carvallo FR, Chapin RE, et al. Comparative assessment of the timing of sexual maturation in male Wistar Han and Sprague-Dawley rats. Reprod Toxicol. 2013;38:16–24. doi:10.1016/j.reprotox.2013.02.00323434729
  • Sengupta P. The laboratory rat: relating its age with human’s. Int J Prev Med. 2013;4(6):624–630.23930179
  • Folwarczna J, Pytlik M, Śliwiński L, Cegieła U, Nowińska B, Rajda M. Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats. Pharmacol Rep. 2011;63(4):1040–1049.22001992
  • Lieber G, Jimenez J, Hunter JC, McLeod RL, Jia Y. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat. Pharmacology. 2010;85(5):311–318. doi:10.1159/00029979220453555
  • Ramanathan R, Alvarez N, Su AD, et al. Metabolism and excretion of loratadine in male and female mice, rats and monkeys. Xenobiotica. 2005;35(2):155–189. doi:10.1080/0049825050003890616019945
  • Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27–31. doi:10.4103/0976-0105.17770327057123
  • Matsushita M, Kitoh H, Ohkawara B, et al. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia. PLoS One. 2013;8(12):e81569. doi:10.1371/journal.pone.008156924324705
  • Simons FER, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008;1(September):145–155. doi:10.1097/WOX.0b013e318186fb3a23282578
  • Dorozhkin SV, Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed. 2002;41(17):3130–3146. doi:10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
  • Rodriguez-Florez N, Garcia-Tunon E, Mukadam Q, et al. An investigation of the mineral in ductile and brittle cortical mouse bone. J Bone Miner Res. 2015;30(5):786–795. doi:10.1002/jbmr.241425418329
  • Combes C, Cazalbou S, Rey C. Apatite biominerals. Minerals. 2016;6(2):34. doi:10.3390/min6020034